Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Dec 2021 for Dicerna Pharmaceuticals Inc, €500k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert D. Ciappenelli: trading record in brief
This profile gathers the share dealings of Robert D. Ciappenelli in Dicerna Pharmaceuticals Inc, where the filings describe the role as senior executive. Over a trading history stretching from 11 June 2021 to 28 December 2021, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 29 December 2021: a transaction of €500k, in Dicerna Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert D. Ciappenelli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
14,813 shares@ US$38.2562.1% of flowCommon StockSEC:0001399529-21-000196:0
3,425 sharesCommon StockSEC:0001399529-21-000177:0
8,856 shares@ US$22.5822.0% of flowCommon StockSEC:0001399529-21-000164:0
10,000 shares@ US$15.6115.9% of flowCommon StockSEC:0001399529-21-000116:0
4 of 4 declarations
